Ledger.Open graph →

SEC Form D · filed January 13, 2017

RespireRx Pharmaceuticals Inc

Offering

$3.0M

Sold

$185K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

GLEN ROCK, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Kathryn E. Macfarlane · Glen Rock, NJDirector James S. Manuso · Glen Rock, NJExec · Director Jeff E. Margolis · Glen Rock, NJExec · Director Richard E. Purcell · Glen Rock, NJExec Arnold S. Lippa · Glen Rock, NJExec · Director James E. Sapirstein · Glen Rock, NJDirector Robert N. Weingarten · Glen Rock, NJExec · Director Peter Mullen · New York, NYDirector Sponsor Colony Hills Capital, LLC · Wilbraham, MADirector Glenn R. Hanson · Wilbraham, MAExec · Director Donald R. Mclamb, Jr · Wilmington, DEExec Luke J. Atwood · Richmond, VAExec · Director Leath Bing · New York, NYExec · Director Amrit Shahzad · Beverly, MADirector Andrew F. St Pierre · Burlington, MAExec · Director Charles Berg · New York, NYExec · Director Christine K. Funk · Sisters, ORExec Matt Harris · New York, NYDirector Clair C. Holley · Calgary, Alberta, CanadaExec · Director Robert N. Weingarten · Glen Rock, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗